Related by context. Frequent words. (Click for all words.) 69 Equinix filings 65 theSecurities 61 ExchangeCommission 61 Medtronic periodic 60 Silicon Image filings 59 Radware Form 57 Securities andExchange Commission 57 Company periodic filings 57 risks anduncertainties 56 Medtronic Annual Report 55 BioSante filings 55 Qualitative Disclosures About 54 BioCryst files 53 Harmonic filings 53 CommScope filings 53 suchforward looking 53 periodic reports 52 Terremark filings 52 'S MOST RECENT 52 periodic filings 52 http:/www.applera.com 52 French Autorité des Marchés 51 BOPET film industry 51 section captioned Risk 51 y h 51 involving hydrophilic liquid 51 successfully commercialize 51 Rules #b 51 EPIX Pharmaceuticals 50 www.combinatorx.com 50 HOLDRS SM 50 Statement Prospectus 50 Risk Factors section 50 HP Quarterly Report 50 headings Forward Looking 50 should consult Cytokinetics 49 assimilating acquired 49 rheumatoid arthritis multiple sclerosis 49 n h 49 Form# K 49 SEC 'S WEBSITE 49 www.norsat.com 49 Company Prospectus dated 49 French Autorite des 49 successfully commercialize REOLYSIN 49 y u 49 Risk Factors Management Discussion 49 Risk Factors 49 r h 48 caption Risk Factors 48 Panzem R 48 Radware filings 48 prospectus supplement dated 48 symbol ACTU 48 Veeco Annual Report 48 Stockholm Iceland Tallinn 48 obtaining regulatory approvals 48 h u 48 Item IA 48 xix 48 rheumatoid arthritis psoriasis 48 Offer Documents 47 heading Risk Factors 47 Statement Regarding Forward Looking 47 diminishing quantities 47 Joint Proxy Statement 47 Abraxis trades 47 Exchange Commission 47 prospectus supplement relating 47 xviii 47 forward.looking statements 47 incorporated therein 47 u t 47 Qualitative Disclosures 47 WWW.SEC.GOV 47 differmaterially 47 R sorafenib tablets 47 Risks uncertainties 47 theforward looking 47 risks uncertainties 47 Parkinson disease Alzheimer disease 47 g o 47 Anadys Form 47 FILED WITH THE 47 Market Nasdaq RIMM 47 u h 47 Definitive Proxy Statement 47 Therein lurks 47 By HARVEY SIMPSON 47 filings 47 xxv 47 t r 47 Rosetta dependence 47 RXi Pharmaceutical Corporation 46 Cautionary Statements sections 46 RHF Seven Summits Strategic 46 RISK FACTORS 46 f h 46 xxii 46 governmental approvals 46 symbol NVO